The present disclosure relates to methods, devices, and systems used for the treatment of and/or promoting recovery from various neurological disorders and conditions, including epilepsy and other seizure disorders and movement and other related disorders； for promoting recovery from acute or chronic brain injury (e.g. stroke, hypoxia/ischemia, head trauma, subarachnoid hemorrhage, and other forms of brain injury, for awakening and/or promoting the recovery of patients in various levels of coma, altered mental status or vegetative state)； or for promoting recovery from chronic daily headache and migraine and related disorders via external (cutaneous) stimulation of the sensory branches of the trigeminal nerve in the face and forehead. More specifically, devices and electrode assemblies configured for stimulation of the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and infratrochlear nerves are disclosed.本開示は、三叉神経の表在要素の刺激（「ＴＮＳ」）による気分障害、不安障害、認知障害、及び行動障害（まとめて、神経精神障害）の治療に使用される方法、装置、及びシステムに関する。より具体的には、顔面において頭蓋外に位置する三叉神経の表在分枝、すなわち、眼窩上神経、滑車上神経、眼窩下神経、耳介側頭神経、頬骨側頭神経、頬骨眼窩神経、頬骨顔面神経、鼻神経及びオトガイ神経（まとめて表在三叉神経とも称される）を刺激する最小侵襲性のシステム、装置及び方法が本明細書に開示される。【選択図】 図１Ａ
